These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11461801)

  • 1. Monotherapy trial design: conversion versus de novo.
    Kälviäinen R
    Epilepsy Res; 2001 May; 45(1-3):75-8; discussion 79-80. PubMed ID: 11461801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy clinical trial design.
    Sachdeo R
    Neurology; 2007 Dec; 69(24 Suppl 3):S23-7. PubMed ID: 18071154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the efficacy of antiepileptic drugs.
    Mohanraj R; Brodie MJ
    Seizure; 2003 Oct; 12(7):413-43. PubMed ID: 12967570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative monotherapy trial designs for the assessment of antiepileptic drugs: a critical appraisal.
    Perucca E
    Eur J Clin Pharmacol; 1998 Mar; 54(1):1-5. PubMed ID: 9591922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
    Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications.
    Perucca E; Tomson T
    Epilepsy Res; 1999 Feb; 33(2-3):247-62. PubMed ID: 10094435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy.
    Perucca E
    Epilepsia; 2010 Oct; 51(10):1933-5. PubMed ID: 20491875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions.
    Perucca E
    CNS Drugs; 2008; 22(11):917-38. PubMed ID: 18840033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative designs of controlled clinical trials in epilepsy.
    Gram L; Schmidt D
    Epilepsia; 1993; 34 Suppl 7():S1-6. PubMed ID: 8243373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
    de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH
    Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy trials: prerequisite data.
    Brodie MJ
    Epilepsy Res; 2001 May; 45(1-3):61-4; discussion 65-6. PubMed ID: 11461797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy comparative trials: placebos and suboptimal comparators.
    Schwabe S
    Epilepsy Res; 2001 May; 45(1-3):93-6; discussion 97-9. PubMed ID: 11461805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
    Balabanova S; Taylor C; Sills G; Burnside G; Plumpton C; Smith PEM; Appleton R; Leach JP; Johnson M; Baker G; Pirmohamed M; Hughes DA; Williamson PR; Tudur-Smith C; Marson AG
    BMJ Open; 2020 Aug; 10(8):e040635. PubMed ID: 32847927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy trials: endpoints.
    Mattson RH
    Epilepsy Res; 2001 May; 45(1-3):109-17; discussion 119, 121-2. PubMed ID: 11461809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin monotherapy for epilepsy.
    Zhou Q; Zheng J; Yu L; Jia X
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009429. PubMed ID: 23076957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: Two double-blind, randomized, multicenter, historical control, Phase III studies.
    Arnold S; Badalamenti V; Diaz A; Gasalla T; McShea C; Whitesides J; Fakhoury T
    Epilepsy Res; 2018 Mar; 141():73-82. PubMed ID: 29486396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.